Genentech is committed to supporting programs open to a broad audience that benefit patients, the scientific or medical community, and/or public health.
Fellowships are for grants to independent professional organizations, independent charitable organizations, or other eligible institutions, where the funds are used to support advanced study by clinical and research professionals at an accredited university or teaching institution.
The mission of Genentech's development program is to provide funding to foster training and research that supports the clinical practice of Genentech therapeutic areas.
Grant requests must be submitted at least 60 days prior to the project/program start date. The following uploads are required to submit your application:
Funding Request System Resources
Learn more about the funding request process
The fellowship program is accredited, or in the case of retina-related fellowships, the program is a 2-year post-residency program
Operating expenses must be directly and exclusively dedicated to the activity for which the requestor is applying
Genentech/Roche will consider funding requests in the following disease states:
In order to be eligible for this type of funding, your organization must not be:
In order to be eligible for this type of funding, the funding must not be used for:
The fellow must not have been identified or selected prior to the funding decision.
An organization with a written policy to discriminate based on race, religion, gender, gender expression and/or identity, age, national origin, disability, marital status, sexual orientation, military status, or any other protected status is ineligible for funding.
Genentech has a rolling review policy when evaluating funding requests for fellowships. This allows qualified requestors the opportunity to apply anytime during year.
Requests must be submitted at least 60 days prior to the project/program start date. Decisions are made on a case-by-case basis; you will usually hear back from Genentech prior to the project/program start date.
All grants must abide by the terms in the Genentech Letter of Agreement (LOA), which is issued to an authorized signer of your organization once the application is approved. You must agree to the terms of the LOA before any funding is issued. If you have any questions on the agreement terms, please contact us at (877) 313-5778.
Note: The funding application site does not support IE8 or earlier